logo-loader
RNS
viewBarclays PLC

FORM 8.3 - TAKEAWAY.COM NV

.bwalignc { text-align: center; list-div-position:inside; } .bwalignl { text-align: left; } .bwalignr { text-align: right; list-div-position:inside; } .bwcellpmargin { margin-bottom: 0px; margin-top: 0px} .bwleftsingle { border-left: solid black 1.0pt} .bwpadl0 { padding-left: 0.0px; } .bwpadr0 { padding-right: 0.0px; } .bwrightsingle { border-right: solid black 1.0pt} .bwrowaltcolor0 {background-color: #CCEEFF} .bwsinglebottom { border-bottom: solid black 1.0pt} .bwtablemarginb { margin-bottom: 10.0px; } .bwtopsingle { border-top: solid black 1.0pt} .bwvertalignb { vertical-align: bottom; } .bwvertalignt { vertical-align: top; } .bwwidth100 { width: 100%; } .bwwidth11 { width: 11%; } .bwwidth12 { width: 12%; } .bwwidth14 { width: 14%; } .bwwidth15 { width: 15%; } .bwwidth19 { width: 19%; } .bwwidth20 { width: 20%; } .bwwidth21 { width: 21%; } .bwwidth22 { width: 22%; } .bwwidth23 { width: 23%; } .bwwidth32 { width: 32%; } .bwwidth48 { width: 48%; } .bwwidth51 { width: 51%; }

FORM 8.3 - TAKEAWAY.COM NV

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Barclays PLC.

 
(b) Owner or controller of interest and short

 

positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose

TAKEAWAY.COM NV

relevant securities this form relates:
(d) If an exempt fund manager connected with an

 

offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken:

09 December 2019

(f) In addition to the company in 1(c) above, is the discloser making

YES:

disclosures in respect of any other party to the offer?

JUST EAT PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: EUR 0.04
Interests Short Positions
Number (%) Number (%)

(1)

Relevant securities owned
and/or controlled:

157,599

0.26%

111,108

0.18%

 

(2)

Cash-settled derivatives:

98,200

0.16%

125,404

0.20%

 

(3)

Stock-settled derivatives (including options)
and agreements to purchase/sell:

0

0.00%

0

0.00%

 
 
TOTAL:

255,799

0.42%

236,512

0.39%

 
Class of relevant security: Convertible Bond XS1940192039
Interests Short Positions
Number (%) Number (%)

(1)

Relevant securities owned
and/or controlled:

2,600,000

1.04%

2,000,000

0.80%

 

(2)

Cash-settled derivatives:

0

0.00%

0

0.00%

 

(3)

Stock-settled derivatives (including options)

 

and agreements to purchase/sell:

0

0.00%

0

0.00%

 
 
TOTAL:

2,600,000

1.04%

2,000,000

0.80%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale

Number of

Price per unit

security

securities

 

Convertible Bond Sale

2,000,000

142.5000 EUR

EUR 0.04 Purchase

3

86.1000 EUR

EUR 0.04 Purchase

7

84.8500 EUR

EUR 0.04 Purchase

15

84.7600 EUR

EUR 0.04 Purchase

53

84.8266 EUR

EUR 0.04 Purchase

366

84.8863 EUR

EUR 0.04 Purchase

1,920

85.5349 EUR

EUR 0.04 Purchase

2,281

84.6545 EUR

EUR 0.04 Purchase

5,636

84.6500 EUR

EUR 0.04 Purchase

6,137

84.8892 EUR

EUR 0.04 Purchase

6,149

84.7742 EUR

EUR 0.04 Purchase

21,575

86.5000 EUR

EUR 0.04 Sale

2

84.6500 EUR

EUR 0.04 Sale

34

85.2000 EUR

EUR 0.04 Sale

148

85.0834 EUR

EUR 0.04 Sale

177

86.0762 EUR

EUR 0.04 Sale

415

85.0420 EUR

EUR 0.04 Sale

6,590

85.3956 EUR

(b) Cash-settled derivative transactions

Class of Product Nature of dealing

Number of

Price per

relevant description

reference

unit

security

securities

 

EUR 0.04 CFD Long

29

84.6413 EUR

EUR 0.04 SWAP Long

44

84.9081 EUR

EUR 0.04 SWAP Long

148

85.0833 EUR

EUR 0.04 SWAP Long

1,137

85.5582 EUR

EUR 0.04 CFD Long

6,006

85.3581 EUR

EUR 0.04 CFD Short

21

86.1585 EUR

EUR 0.04 SWAP Short

53

84.8266 EUR

EUR 0.04 SWAP Short

225

84.7352 EUR

EUR 0.04 SWAP Short

238

84.3037 EUR

EUR 0.04 SWAP Short

300

84.8833 EUR

EUR 0.04 CFD Short

1,313

84.8202 EUR

EUR 0.04 SWAP Short

5,101

84.8977 EUR

EUR 0.04 CFD Short

5,636

84.6500 EUR

EUR 0.04 SWAP Short

7,599

84.9818 EUR

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

10 Dec 2019

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

BARCLAYS PLC

Quick facts: Barclays PLC

Price: 175.43

Market: LSE
Market Cap: £30.39 billion
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

RNS

Form 8.3 - Abbvie Plc - Amendment

2 days, 21 hours ago

Form 8.3 - CONSORT MEDICAL PLC

2 days, 22 hours ago

Form 8.3 - COBHAM PLC

2 days, 22 hours ago

FORM 8.3 - ALLERGAN PLC

2 days, 23 hours ago

FORM 8.3 - ABBVIE PLC

2 days, 23 hours ago

Form 8.3 - Sirius Minerals plc

2 days, 23 hours ago

Form 8.3 - Charles Taylor plc

2 days, 23 hours ago